Role of Canadian pharmacists in managing drug shortage concerns amid the COVID-19 pandemic.
作者信息
Elbeddini Ali, Hooda Naushin, Yang Lucy
机构信息
Winchester District Memorial Hospital (Elbeddini), Winchester.
Industrial Pharmacy Residency Program (Hooda), University of Toronto.
出版信息
Can Pharm J (Ott). 2020 May 29;153(4):198-203. doi: 10.1177/1715163520929387. eCollection 2020 Jul-Aug.
Abstract
摘要
相似文献
1
Role of Canadian pharmacists in managing drug shortage concerns amid the COVID-19 pandemic.
Can Pharm J (Ott). 2020 May 29;153(4):198-203. doi: 10.1177/1715163520929387. eCollection 2020 Jul-Aug.
2
Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward.
Front Public Health. 2020 Dec 8;8:561924. doi: 10.3389/fpubh.2020.561924. eCollection 2020.
3
Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine.
J Pharm Policy Pract. 2020 May 27;13:23. doi: 10.1186/s40545-020-00229-z. eCollection 2020.
4
Canadian Hospital Pharmacists' Perceptions of Workplace Preparedness and Personal Well-Being during the COVID-19 Pandemic.
Can J Hosp Pharm. 2022 Oct 3;75(4):276-285. doi: 10.4212/cjhp.3225. eCollection 2022 Fall.
5
The COVID conversations: A content analysis of Canadian pharmacy organizations' communication of pharmacists' roles and services during the COVID-19 pandemic.
Can Pharm J (Ott). 2022 Dec 10;156(1):22-31. doi: 10.1177/17151635221139195. eCollection 2023 Jan-Feb.
6
Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.
Am J Health Syst Pharm. 2021 Mar 18;78(7):613-618. doi: 10.1093/ajhp/zxab003.
7
Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage.
J Pharm Policy Pract. 2020 May 20;13:19. doi: 10.1186/s40545-020-00224-4. eCollection 2020.
8
Pharmacists and COVID-19.
J Pharm Policy Pract. 2020 Jun 19;13:36. doi: 10.1186/s40545-020-00241-3. eCollection 2020.
9
Impact of the COVID-19 pandemic on pharmacy practice and on the provision of pharmaceutical care: A cross-sectional study among community pharmacists.
J Med Access. 2023 Mar 31;7:27550834231161145. doi: 10.1177/27550834231161145. eCollection 2023 Jan-Dec.
10
Under the Microscope: A Look Into the Role of Critical Care Pharmacists During the COVID-19 Pandemic.
J Pharm Pract. 2022 Dec;35(6):1007-1011. doi: 10.1177/08971900211013991. Epub 2021 May 18.
引用本文的文献
1
Impact of the COVID-19 Pandemic on Hospital Antimicrobial Purchasing in Canada (2018-2021): An Exploratory Analysis.
J Assoc Med Microbiol Infect Dis Can. 2025 May 29;10(2):146-159. doi: 10.3138/jammi-2024-0017. eCollection 2025 Jun.
2
Addressing Drug Shortages at Mediclinic Parkview Hospital: A Five-Year Study of Challenges, Impact, and Strategies.
Cureus. 2024 Dec 25;16(12):e76377. doi: 10.7759/cureus.76377. eCollection 2024 Dec.
3
Enabling pharmacist prescribing: Lessons learned in Nova Scotia using behaviour change theory.
Can Pharm J (Ott). 2024 Nov 11;158(1):29-40. doi: 10.1177/17151635241280724. eCollection 2025 Jan-Feb.
4
Impact of supply chain disruptions and drug shortages on drug utilization: A scoping review protocol.
PLoS One. 2024 Nov 1;19(11):e0313298. doi: 10.1371/journal.pone.0313298. eCollection 2024.
5
Digitalization enhancement in the pharmaceutical supply network using a supply chain risk management approach.
Sci Rep. 2023 Dec 15;13(1):22287. doi: 10.1038/s41598-023-49606-z.
6
Pharmacy Students' and Pharmacist Preceptors' Perceptions of the Hospital Rotation Experience during the COVID-19 Pandemic.
Can J Hosp Pharm. 2023 Mar 1;76(2):117-125. doi: 10.4212/cjhp.3303. eCollection 2023 Spring.
7
Monitoring a Mandatory Nonmedical Switching Policy from Originator to Biosimilar Infliximab in Patients with Inflammatory Bowel Diseases: A Population-Based Cohort Study.
Gastroenterol Res Pract. 2023 Mar 1;2023:2794220. doi: 10.1155/2023/2794220. eCollection 2023.
8
Increased self-reported pharmacist prescribing during the COVID-19 pandemic: Using the Theoretical Domains Framework to identify barriers and facilitators to prescribing.
Res Social Adm Pharm. 2023 Jan;19(1):133-143. doi: 10.1016/j.sapharm.2022.08.014. Epub 2022 Aug 20.
9
Mandatory nonmedical switching from originator to biosimilar infliximab in patients with inflammatory arthritis and psoriasis in British Columbia: a cohort study.
CMAJ Open. 2022 Feb 15;10(1):E109-E118. doi: 10.9778/cmajo.20200319. Print 2022 Jan-Mar.
10
Extent of a valsartan drug shortage and its effect on antihypertensive drug use in the Canadian population: a national cross-sectional study.
CMAJ Open. 2021 Dec 7;9(4):E1128-E1133. doi: 10.9778/cmajo.20200232. Print 2021 Oct-Dec.
本文引用的文献
1
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
Clin Infect Dis. 2020 Apr 27. doi: 10.1093/cid/ciaa478.
2
COVID-19: a novel coronavirus and a novel challenge for critical care.
Intensive Care Med. 2020 May;46(5):833-836. doi: 10.1007/s00134-020-05955-1. Epub 2020 Mar 3.
Zotero 插件